PRELUDE CAPITAL MANAGEMENT, LLC

Position in DHR — Danaher Corp /De/

CIK 1387508 NEW YORK, NY

Position in DHR

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$510,592

+$302,188 QoQ

Shares Held

2,693

+155.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

PRELUDE CAPITAL MANAGEMENT, LLC holds $9,521,154 across 13 Diagnostics & Research names. DHR ranks #7 (5.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SHC	Sotera Health Co	108,608	$1,557,438
2	GH	Guardant Health, Inc.	16,636	$1,536,667
3	NTRA	Natera, Inc.	5,676	$1,135,143
4	TWST	Twist Bioscience Corp	21,687	$1,030,566
5	FLGT	Fulgent Genetics, Inc.	56,309	$895,313
6	IQV	Iqvia Holdings Inc.	5,138	$876,234
7	DHR	Danaher Corp /De/ This page	2,693	$510,592
8	TMO	Thermo Fisher Scientific Inc.	836	$410,919

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$510,592	2,693	+155.3%	Shares	Other	2026-05-15
2025-06-30	$208,404	1,055	-93.7%	Shares	Other	2025-08-14
2024-12-31	$3,832,796	16,697	+41.8%	Shares	Other	2025-02-14
2024-09-30	$3,274,797	11,779	+114.8%	Shares	Other	2024-11-14
2024-06-30	$1,369,927	5,483	-45.0%	Shares	Other	2024-08-14
2024-03-31	$2,488,709	9,966	+23.8%	Shares	Other	2024-05-15
2023-12-31	$1,862,981	8,053	-16.2%	Shares	Other	2024-02-14
2023-09-30	$2,114,788	9,615	+789.5%	Shares	Other	2023-11-14
2022-12-31	$254,360	1,081	-34.6%	Shares	Other	2023-02-14
2022-06-30	$371,289	1,652	+126.9%	Shares	Other	2022-08-24
2022-03-31	$189,312	728	-6.7%	Shares	Other	2022-05-16
2021-12-31	$227,506	780	-54.9%	Shares	Other	2022-02-14
2020-03-31	$212,277	1,730	—	Shares	Other	2020-05-15
No filing history on record for this holder in this stock.